Tag: ENTPD1

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to ENTPD1

Victory Capital Management Inc. Invests $9.26 Million in Surface Oncology Inc (SURF) Stock

Added to Collection on: 2018-09-12 09:41:15

Tags for this article:

Finance
NASDAQ
Financial markets
Economy of New York City
Investment
Surface Oncology Inc.
ENTPD1

Click the tags to see associated articles and topics

View Article Details
InteRNA Technologies secures €18.5m in Series B financing

Added to Collection on: 2021-02-10 06:45:00

Tags for this article:

Branches of biology
Medical specialties
Clusters of differentiation
Biology
Immunology
Immune system
T cells
Cell biology
Regulatory T cell
Tumor microenvironment
LAG3
ENTPD1

Click the tags to see associated articles and topics

View Article Details
Surface Oncology to Participate in Upcoming March Investor Conferences

Added to Collection on: 2021-02-24 12:00:00

Tags for this article:

Clinical medicine
Medicine
Branches of biology
T cells
Immunotherapy
Virotherapy
Cancer immunotherapy
Tumor microenvironment
ENTPD1
Regulatory T cell
Surface Oncology

Click the tags to see associated articles and topics

View Article Details
Immunotherapies Expose and Exploit Cancer's Varied Weaknesses

Added to Collection on: 2021-03-04 11:48:45

Tags for this article:

Clinical medicine
Medical specialties
Medicine
Clusters of differentiation
Cancer immunotherapy
Virotherapy
Immune system
Immunotherapy
ENTPD1
NT5E
Immunology
Natural killer cell

Click the tags to see associated articles and topics

View Article Details
Adenosine Triphosphate (ATP), Energy for Your Cells, but Inflammatory Towards Cancer

Added to Collection on: 2021-06-08 14:11:48

Tags for this article:

Branches of biology
Medical specialties
Cell signaling
Clusters of differentiation
Adenosine receptors
Immune system
G protein-coupled receptors
ENTPD1
NT5E
Purinergic signalling
Immune checkpoint
Adenosine A2A receptor
Adenosine

Click the tags to see associated articles and topics

View Article Details
Elpiscience Announces First Patient Dosed in US Phase I Clinical Trial of Anti-CD39 ...

Added to Collection on: 2022-01-20 17:46:08

Tags for this article:

Life Sciences
Clinical medicine
Medicine
Cancer immunotherapy
Biotechnology
ENTPD1
Immunotherapy
Tumor microenvironment
Biopharmaceutical
Elpiscience Biopharmaceuticals, Inc.

Click the tags to see associated articles and topics

View Article Details
Innate Pharma : Announces IPH5201 Phase 2 Study in Lung Cancer - Form 6-K

Added to Collection on: 2022-06-03 11:11:17

Tags for this article:

Life Sciences
Health sciences
Health care
Clusters of differentiation
AstraZeneca
Medical research
Södertälje Municipality
ENTPD1
Oxford–AstraZeneca COVID-19 vaccine
NT5E
Tumor microenvironment
Bristol-Myers Squibb
France
INNATE PHARMA S . A
Marseille

Click the tags to see associated articles and topics

View Article Details
Innate Pharma Announces IPH5201 Phase 2 Study in Lung Cancer - PipelineReview.com

Added to Collection on: 2022-06-03 14:25:28

Tags for this article:

Life Sciences
Health care
Companies
AstraZeneca
Medical research
Södertälje Municipality
Immune system
ENTPD1
Bristol-Myers Squibb
Oxford–AstraZeneca COVID-19 vaccine
Sanofi
Natural killer cell
France
CD39
Innate Pharma S.A.
Marseille

Click the tags to see associated articles and topics

View Article Details
Repurposed Drug Can Target Cancer Cells' Shield Against Immune System

Added to Collection on: 2022-08-25 08:52:36

Tags for this article:

Enzymes
Medicine
Immunology
Cancer treatments
ENTPD1
Cancer immunotherapy
Kinase
Ectonucleotidase
Ceritinib
Cancer
Protein kinase
Immune system
CD39

Click the tags to see associated articles and topics

View Article Details
A membrane ATPase without transporter activity

Added to Collection on: 2022-09-29 01:49:05

Tags for this article:

Branches of biology
Purinergic signalling
Nucleotides
Cell biology
Cell signaling
G protein-coupled receptors
ENTPD1
Platelet
Adenosine triphosphate
Apyrase
Na+/K+-ATPase
Purinergic receptor
Nancy Kleckner Guidotti
Ting-Fang Wang
Guido Guidotti

Click the tags to see associated articles and topics

View Article Details